Skip to content
10-Q

Quarterly Report

CAS MEDICAL SYSTEMS INC

0001072613-17-000555

← back to feed
Filed
Nov 9, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 6, 2017 28.23M sh
Long Term Debt Q3 2017 · Sep 30, 2017 $5.87M
Long Term Debt Q3 2017 · Dec 31, 2016 $6.89M
Short Term Debt Q3 2017 · Sep 30, 2017 $2.13M
Short Term Debt Q3 2017 · Dec 31, 2016 $1.11M
Stockholders Equity Q3 2017 · Sep 30, 2017 $3.78M
Stockholders Equity Q3 2017 · Dec 31, 2016 $3.41M
Current Liabilities Q3 2017 · Sep 30, 2017 $4.56M
Current Liabilities Q3 2017 · Dec 31, 2016 $4.32M
Total Liabilities Q3 2017 · Sep 30, 2017 $10.58M
Total Liabilities Q3 2017 · Dec 31, 2016 $11.31M
Current Assets Q3 2017 · Sep 30, 2017 $11.2M
Current Assets Q3 2017 · Dec 31, 2016 $11.38M
Total Assets Q3 2017 · Sep 30, 2017 $14.36M
Total Assets Q3 2017 · Dec 31, 2016 $14.72M
Capex Q3 2017 · Sep 30, 2016 $1.02M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $6.71M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $7.53M
Sga Expense restated Q3 2017 · Sep 30, 2016 $3.19M
Sga Expense restated Q3 2017 · Sep 30, 2016 $10.05M
Rd Expense restated Q3 2017 · Sep 30, 2016 $813.89K
Rd Expense restated Q3 2017 · Sep 30, 2016 $2.55M
Net Income Q3 2017 · Sep 30, 2016 −$1.35M
Net Income Q3 2017 · Sep 30, 2016 −$1.6M
Operating Income restated Q3 2017 · Sep 30, 2016 −$1.35M
Operating Income restated Q3 2017 · Sep 30, 2016 −$4.98M
Gross Profit restated Q3 2017 · Sep 30, 2016 $2.65M
Gross Profit restated Q3 2017 · Sep 30, 2016 $7.63M